AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-114.95M
↓ 68% below average
Average (9y)
$-68.45M
Historical baseline
Range
High:$-3.02M
Low:$-164.41M
CAGR
+48.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-114.95M | +30.1% |
| 2023 | $-164.41M | -42.8% |
| 2022 | $-115.15M | -102.7% |
| 2021 | $-56.81M | -137.9% |
| 2020 | $-23.88M | +77.8% |
| 2019 | $-107.43M | -61.0% |
| 2018 | $-66.72M | -131.8% |
| 2017 | $-28.78M | -851.4% |
| 2016 | $-3.02M | +8.9% |
| 2015 | $-3.32M | - |